NCT00348881View on ClinicalTrials.gov

Study Comparing a DTaP-HB-PRP~T Combined Vaccine With Tritanrix HepB/Hib™, Concomitantly With OPV in Healthy Infants

PHASE3CompletedINTERVENTIONAL
Enrollment

2,133

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

October 31, 2007

Study Completion Date

June 30, 2008

Conditions
DiphtheriaTetanusPertussisHepatitis BInfluenza
Interventions
BIOLOGICAL

DTaP-HB-PRP~T combined vaccine

0.5 mL, Intramuscular

BIOLOGICAL

Tritanrix-HepB/Hib™ vaccine

0.5 mL, Intramuscular

BIOLOGICAL

Oral poliomyelitis vaccine (OPV)

Oral co-administered with study vaccine.

Trial Locations (4)

Unknown

Alabang

Putatan

Tunasan

Filinvest, Corporate City

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT00348881 - Study Comparing a DTaP-HB-PRP~T Combined Vaccine With Tritanrix HepB/Hib™, Concomitantly With OPV in Healthy Infants | Biotech Hunter | Biotech Hunter